About Stefan Larson
Form D filings for Lenz Therapeutics in 2023 list Stefan Larson as director.
Stefan Larson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Stefan Larson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stefan Larson works with at each company, as listed on that company's latest Form D.
Lenz Therapeutics, Inc. · Form D, Mar 10, 2023
ES
Evert Schimmelpennink
President & CEO, director
JM
James McCollum
Director
CO
Clare Ozawa
Director
ZS
Zach Scheiner
Director
FG
Frederic Guerard
Director
Chris Dimitropoulos
Director